News - Biotechnology
CSL Chief Scientific Officer elected as Fellow of Australian Academy of Science for outstanding contribution

Professor Andrew Cuthbertson, Chief Scientific Officer and Director of CSL is among a group of Australian scientists being acknowledged for their outstanding contributions to science.
Professor Cuthbertson is one of 24 scientists elected as a Fellow of the Australian Academy of Science. He was thrilled to join such a distinguished group with scientific excellence as their guiding principle.
Australian Academy of Science President, Professor John Shine AC, congratulated the new Fellows for making significant and lasting impacts in their scientific disciplines.
“These scientists were elected by their Academy peers following a rigorous evaluation process,” said Professor Shine.
Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
Women make up 42% of this year’s new Fellows.
“The number of women in this year’s elected Fellows reflects the Academy’s work to apply best practice in our nomination and election processes.
“We encourage the STEM sector to continue to nurture diversity in all its forms, so that the STEM workforce reflects the composition of our society,” Professor Shine said.
Over the past five years, 34% of the Fellows elected have been women. Following this year’s election, the Fellowship stands at 559 Fellows, 90 of whom are women.
In alignment with the Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to support Pharma, Biotech and MedTech industry professionals. The initiative is supported by Medicines Australia, AusBiotech, MTAA and ARCS Australia. Learn more.
Human Resources
Merck puts the ‘family’ in workplace as fertility survey exposes gaps
Merck has announced the results of its Fertility Futures Survey of 1,500 Australians aged 18 to 35, revealing significant gaps […]
MoreNews - MedTech & Diagnostics
Australia has a new genomics framework. But will patients see the difference?
The government has released the National Health Genomics Policy Framework and Implementation Plan 2026–2030, jointly developed by the federal and […]
MoreNews - Pharmaceuticals
PCFA condemns funding axe and demands Prime Minister intervene
The Prostate Cancer Foundation of Australia (PCFA) has condemned the Albanese Government’s decision to end funding for its national Prostate […]
MoreNews - Pharmaceuticals
Sanofi’s clinical-trial push hits a GP reality check
New research from Sanofi presented at the Australian Public Health Conference this week points to an addressable opportunity to increase […]
More